Busca avançada
Ano de início
Entree


Antiparasitic properties of 4-nerolidylcatechol from Pothomorphe umbellata (L.) Miq. (Piperaceae) in vitro and in mice models with either prepatent or patent Schistosoma mansoni infections

Texto completo
Autor(es):
Mostrar menos -
Costa, Danilo de Souza ; Leal, Carla Monteiro ; Cajas, Rayssa A. ; Gazolla, Matheus Coutinho ; Silva, Livia Mara ; de Carvalho, Lara Soares Aleixo ; Lemes, Bruna L. ; de Moura, Renato Oliveira ; de Almeida, Juliana ; de Moraes, Josue ; da Silva Filho, Ademar A.
Número total de Autores: 11
Tipo de documento: Artigo Científico
Fonte: Journal of Ethnopharmacology; v. 313, p. 11-pg., 2023-05-09.
Resumo

Ethnopharmacological relevance: Roots of Pothomorphe umbellata (L.) Miq. are used in traditional medicine of Africa and South America for the treatment of malaria and helminthiasis. However, neither P. umbellata nor its isolated compounds have been evaluated against Schistosoma species.Aims of this study: To investigate the antischistosomal effects of P. umbellata root extracts and the isolated compound 4-nerolidylcatechol (4-NC) against Schistosoma mansoni ex vivo and in murine models of schistosomiasis.Materials and methods: The crude hydroalcoholic (PuE) and hexane (PuH) extracts of P. umbellata roots were prepared and initially submitted to an ex vivo phenotypic screening against adult S. mansoni. PuH was analyzed by HPLC-DAD, characterized by UHPLC-HRMS/MS, and submitted to chromatographic fractionation, leading to the isolation of 4-NC. The anthelmintic properties of 4-NC were assayed ex vivo against adult schistosomes and in murine models of schistosomiasis for both patent and prepatent S. mansoni infections. Praziquantel (PZQ) was used as a reference compound.Results: PuE (EC50: 18.7 mu g/mL) and PuH (EC50: 9.2 mu g/mL) kill adult schistosomes ex vivo. The UHPLC-HRMS/ MS analysis of PuH, the most active extract, revealed the presence of 4-NC, peltatol A, and peltatol B or C. After isolation from PuH, 4-NC presented remarkable in vitro schistosomicidal activity with EC50 of 2.9 mu M (0.91 mu g/ mL) and a selectivity index higher than 68 against Vero mammalian cells, without affecting viability of nematode Caenorhabditis elegans. In patent S. mansoni infection, the oral treatment with 4-NC decreased worm burden and egg production in 52.1% and 52.3%, respectively, also reducing splenomegaly and hepatomegaly. 4-NC, unlike PZQ, showed in vivo efficacy against juvenile S. mansoni, decreasing worm burden in 52.4%.Conclusions: This study demonstrates that P. umbellata roots possess antischistosomal activity, giving support for the medicinal use of this plant against parasites. 4-NC was identified from P. umbellata roots as one of the effective in vitro and in vivo antischistosomal compound and as a potential lead for the development of novel anthelmintics. (AU)

Processo FAPESP: 20/01441-4 - Seleção de fármacos com atividade anti-helmíntica, nanoencapsulação e avaliação pré-clínica em modelo experimental de esquistossomose
Beneficiário:Josué de Moraes
Modalidade de apoio: Auxílio à Pesquisa - Regular
Processo FAPESP: 16/22488-3 - Reposicionamento de fármacos para doenças negligenciadas: identificação de novos agentes anti-helmínticos
Beneficiário:Josué de Moraes
Modalidade de apoio: Auxílio à Pesquisa - Regular